POASHealthcare · Medical Devices

POAS Stock Forecast: Phaos Technology Holdings (Cayman) Ltd. Price Predictions for 2026-2027

Last close, 31 July 2026
$0.19

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 1 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap
$6.0M
Ticker Nerd rank
1 / 100
Median analyst target
Analysts covering
Ticker Nerd rank

POAS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Phaos Technology Holdings (Cayman) Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
1 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
95
Revisions
25
Growth
8
Accruals
8
Value
4
Volatility
3
Quality
3
Issuance
0
Momentum
0

Size (95): Smaller than most of the companies we track.

Momentum (0): The shares have been drifting down relative to others.

The rank is the raw material. Whether the rules would actually own Phaos Technology Holdings (Cayman) Ltd. — and when they’d sell — is the membership.

Wall Street

POAS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on POAS, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

POAS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Phaos Technology Holdings (Cayman) Ltd. (POAS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
Price / sales
31.2×

Cheaper than 7% of US stocks

Price / book
EV / EBITDA
−2.6×

Cheaper than 74% of US stocks

Growth & margins
Revenue growth (YoY)
38.8%

Higher than 83% of US stocks

Earnings growth (YoY)
Gross margin
Operating margin
−1762.4%

Higher than 5% of US stocks

Net margin
22.1%

Higher than 84% of US stocks

Returns & dividend
Return on equity
261.7%

Higher than 98% of US stocks

Return on assets
−102.2%

Higher than 2% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

POAS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
POASPhaos Technology Holdings (Cayman) Ltd.$6.0M
1
VVOSVivos Therapeutics, Inc.$5.5M
12
AIDX20/20 Biolabs, Inc.$5.2M
2
WOKWORK Medical Technology Group Ltd.$4.8M
2
ITOCiTonic Holdings Ltd.$4.6M
23
BMRABiomerica, Inc.$4.5M
35
INBSIntelligent Bio Solutions, Inc.$4.3M
10
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. POAS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

FAQ

Frequently asked questions about POAS stock

How does Ticker Nerd's model rank POAS?

As at 1 Aug 2026, Phaos Technology Holdings (Cayman) Ltd. ranks 1 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (95 of 100).

What is the POAS stock forecast for 2030?

No analyst covering Phaos Technology Holdings (Cayman) Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for POAS are extrapolating price history, which says nothing about the business.

What does Phaos Technology Holdings (Cayman) Ltd. do?

Phaos Technology Holdings (Cayman) Limited is an investment holding company specializing in the development, assembly, and commercialization of advanced microscopy solutions. Through its primary operating subsidiary, the company delivers a portfolio of high-precision imaging technologies, including super-resolution imagers capable of visualizing features at the nanometer scale, specialized microscopes tailored for diverse industrial and biomedical applications, and three-dimensional real-time image magnifiers for enhanced visualization and measurement.

Company

About Phaos Technology Holdings (Cayman) Ltd.

Phaos Technology Holdings (Cayman) Limited is an investment holding company specializing in the development, assembly, and commercialization of advanced microscopy solutions. Through its primary operating subsidiary, the company delivers a portfolio of high-precision imaging technologies, including super-resolution imagers capable of visualizing features at the nanometer scale, specialized microscopes tailored for diverse industrial and biomedical applications, and three-dimensional real-time image magnifiers for enhanced visualization and measurement. Leveraging artificial intelligence, Phaos Technology’s systems are designed to support sectors such as manufacturing, life sciences, and research, enabling clients to achieve greater accuracy in inspection, diagnostics, and analysis. Headquartered in Singapore and incorporated under Cayman Islands law, Phaos Technology Holdings plays a vital role in driving optical innovation, offering essential tools that advance scientific and industrial capabilities worldwide. The Class A Ordinary Shares provide investors with exposure to a technologically focused company positioned at the intersection of next-generation imaging and precision measurement solutions.

CEO Mr. Hong Loon Gan · 10 employees · Singapore · https://phaostech.com